Eve & Co Incorporated

Background

Eve & Co Incorporated, through its wholly-owned subsidiary Natural MedCo Ltd., is a Canadian licensed producer of cannabis products, including dried cannabis, cannabis plants, and cannabis oil. Founded in 2013 and headquartered in Strathroy, Ontario, the company is recognized as Canada's first female-founded licensed producer of medicinal marijuana, receiving its cultivation license from Health Canada in 2016.

Key Strategic Focus

Eve & Co is dedicated to producing high-quality cannabis products with a particular emphasis on the female consumer market. The company's strategic objectives include:

• Product Diversification: Offering a range of products such as dried flower, pre-rolls, bath bombs, and beverages tailored to women's preferences.

• Market Expansion: Targeting both domestic and international markets, including medical and recreational cannabis sectors.

• Operational Excellence: Utilizing advanced greenhouse technologies to optimize cultivation and production processes.

Financials and Funding

In the first half of 2021, Eve & Co reported gross revenues of $4.0 million, surpassing its total gross revenues of $3.8 million for the entire 2020 financial year.

In September 2021, the company completed a private placement of 2,777,778 units at a price of $0.18 per unit, raising gross proceeds of $500,000. The net proceeds were intended for working capital and general corporate purposes.

Pipeline Development

Eve & Co has developed a diverse product portfolio, including:

• Bath Bombs: Launched in November 2020, these cannabis-infused bath bombs cater to women seeking self-care products.

• Beverages: Collaborated with Ontario's Colio Estate Wines to develop a cannabis-infused, non-alcoholic wine substitute.

• Topicals: Entered into an exclusive agreement with Dr. Kerklaan Therapeutics to manufacture and distribute CBD-infused topicals in Canada.

Technological Platform and Innovation

Eve & Co operates a state-of-the-art, 1,000,000 square foot greenhouse facility in Strathroy, Ontario, featuring:

• Advanced Greenhouse Design: Incorporates full butterfly roofs for optimal air circulation and diffused glass to enhance light uniformity.

• Automation: Utilizes automated systems for climate control, irrigation, and fertigation to ensure consistent product quality.

• Environmental Sustainability: Implements water reclamation systems and CO₂ enrichment to optimize plant growth while minimizing environmental impact.

Leadership Team

• Melinda Rombouts: President and Chief Executive Officer. As the founder, she brings extensive experience in greenhouse operations and a vision for female-focused cannabis products.

• Landon Roedding: Chief Financial Officer. Oversees the company's financial strategy and operations.

Competitor Profile

Market Insights and Dynamics

The global cannabis market has experienced significant growth, with increasing legalization and acceptance of cannabis products for both medical and recreational use. The female consumer segment represents a substantial and often underserved market within the industry.

Competitor Analysis

Key competitors in the cannabis industry include:

• Canopy Growth Corporation: A leading cannabis company with a diverse product portfolio and international presence.

• Aurora Cannabis Inc.: Focuses on both medical and recreational cannabis markets with extensive production facilities.

• Aphria Inc.: Offers a range of cannabis products and has engaged in strategic mergers to expand its market share.

Eve & Co differentiates itself by targeting the female demographic, offering products specifically designed for women's preferences and needs.

Strategic Collaborations and Partnerships

Eve & Co has established several strategic partnerships to enhance its market position:

• Dr. Kerklaan Therapeutics: Entered into an exclusive agreement to manufacture and distribute CBD-infused topicals in Canada.

• Colio Estate Wines: Collaborated to develop a cannabis-infused, non-alcoholic wine substitute.

• Cannamedical Pharma GmbH: Signed a supply agreement to export medical-grade dried cannabis flower to Germany.

Operational Insights

Eve & Co's competitive advantages include:

• Female-Focused Branding: A unique market position targeting the female consumer segment.

• Advanced Cultivation Facilities: A large-scale, technologically advanced greenhouse enabling efficient and high-quality production.

• International Expansion: EU GMP certification facilitating entry into European markets, particularly Germany.

Strategic Opportunities and Future Directions

Eve & Co aims to:

• Expand Product Offerings: Continue developing and launching products that cater to women's health and wellness.

• Increase International Presence: Leverage EU GMP certification to enter additional European markets.

• Enhance Production Capabilities: Invest in further automation and sustainable practices to improve efficiency and environmental responsibility.

Contact Information

For more information, visit Eve & Co's official website: www.evecannabis.ca